Search alternatives:
significantly lower » significantly higher (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
better decrease » teer decrease (Expand Search), between decreased (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
significantly lower » significantly higher (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
better decrease » teer decrease (Expand Search), between decreased (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
-
1441
Combined Confusion matrix: (a) Rear hand punch classification (b) Lead hand punch classification.
Published 2025Subjects: -
1442
-
1443
-
1444
-
1445
-
1446
-
1447
-
1448
-
1449
-
1450
-
1451
-
1452
Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste...
Published 2025“…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…”
-
1453
Advantages of Novel Anti-cancer Selenosemicarbazones: Preferential Reactivity of Their Fe(III), Cu(II), and Zn(II) Complexes with Key Physiological Reductants/Ligands Versus Isoste...
Published 2025“…The role of glutathione in all three latter reactions is significant, given the greater reactivity of the selenosemicarbazone, and glutathione’s key role in selenosemicarbazone and thiosemicarbazone anticancer activity.…”
-
1454
Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality.
Published 2024Subjects: -
1455
Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE.
Published 2024Subjects: -
1456
-
1457
Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events.
Published 2024Subjects: -
1458
-
1459
The Laboratory Animal Flow Diagram.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
-
1460
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025“…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”